TW200716622A - Substituted piperidines - Google Patents

Substituted piperidines

Info

Publication number
TW200716622A
TW200716622A TW095110894A TW95110894A TW200716622A TW 200716622 A TW200716622 A TW 200716622A TW 095110894 A TW095110894 A TW 095110894A TW 95110894 A TW95110894 A TW 95110894A TW 200716622 A TW200716622 A TW 200716622A
Authority
TW
Taiwan
Prior art keywords
substituted piperidines
explained
compounds
piperidines
detail
Prior art date
Application number
TW095110894A
Other languages
English (en)
Chinese (zh)
Inventor
Peter Herold
Robert Mah
Vincenzo Tschinke
Michael Quirmbachi
Aleksandar Stojanovic
Dirk Behnke
Christiane Marti
Frank Hollinger
Zenon D Konteatis
Jennifer L Ludington
Stefan Stutz
Stjepan Jelakovic
Original Assignee
Speedel Experimenta Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Experimenta Ag filed Critical Speedel Experimenta Ag
Publication of TW200716622A publication Critical patent/TW200716622A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
TW095110894A 2005-03-31 2006-03-29 Substituted piperidines TW200716622A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66655605P 2005-03-31 2005-03-31
US75085305P 2005-12-16 2005-12-16

Publications (1)

Publication Number Publication Date
TW200716622A true TW200716622A (en) 2007-05-01

Family

ID=36586065

Family Applications (2)

Application Number Title Priority Date Filing Date
TW095110894A TW200716622A (en) 2005-03-31 2006-03-29 Substituted piperidines
TW097113173A TW200833687A (en) 2005-03-31 2006-03-29 Substituted piperidines

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW097113173A TW200833687A (en) 2005-03-31 2006-03-29 Substituted piperidines

Country Status (13)

Country Link
US (2) US20100029628A1 (OSRAM)
EP (1) EP1863803B1 (OSRAM)
JP (2) JP2008534558A (OSRAM)
AR (2) AR055756A1 (OSRAM)
AT (1) ATE479681T1 (OSRAM)
BR (2) BRPI0621969A2 (OSRAM)
CA (1) CA2601702A1 (OSRAM)
DE (1) DE602006016573D1 (OSRAM)
IL (2) IL186130A0 (OSRAM)
PL (1) PL1863803T3 (OSRAM)
PT (1) PT1863803E (OSRAM)
TW (2) TW200716622A (OSRAM)
WO (1) WO2006103277A2 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008510755A (ja) 2004-08-25 2008-04-10 アクテリオン ファーマシューティカルズ リミテッド ビシクロノネン誘導体
AR055756A1 (es) * 2005-03-31 2007-09-05 Speedel Experimenta Ag Piperidinas sustituidas; procesos de preparacion y su uso como medicamentos
KR100963455B1 (ko) 2005-05-27 2010-06-18 액테리온 파마슈티칼 리미티드 신규한 피페리딘 카르복실산 아미드 유도체
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
EP2018380B1 (en) 2006-05-19 2011-10-19 Abbott Laboratories Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
AR061265A1 (es) * 2006-06-08 2008-08-13 Speedel Experimenta Ag Piperidinas 2,5- disustituidas
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
EP1958634A3 (en) * 2007-02-14 2008-09-24 Speedel Experimenta AG Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease
AR069005A1 (es) * 2007-10-25 2009-12-23 Speedel Experimenta Ag Piperidinas 4,4-disustituidas
TW200934499A (en) * 2007-11-02 2009-08-16 Speedel Experimenta Ag 4,4-disubstituted piperidines
RU2010129690A (ru) 2007-12-19 2012-01-27 Дайниппон Сумитомо Фарма Ко., Лтд. (Jp) Бициклические гетероциклические производные
JP2011511038A (ja) 2008-02-08 2011-04-07 ノバルティス アーゲー レニン阻害剤としての置換ピペリジン
EA201001239A1 (ru) 2008-02-08 2011-04-29 Новартис Аг Замещённые пиперидины в качестве ингибиторов ренина
CN102015682B (zh) 2008-05-05 2014-07-16 埃科特莱茵药品有限公司 作为肾素抑制剂的3,4-取代的哌啶衍生物
EP2163245A1 (en) 2008-09-10 2010-03-17 Novartis Ag Renin inhibitors for the treatment of psoriasis
US8389731B2 (en) * 2009-05-15 2013-03-05 Northwestern University Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
CA2765527A1 (en) 2009-06-24 2010-12-29 Satoshi Suetsugu N-substituted-cyclic amino derivative
AU2016205036B2 (en) * 2015-01-09 2019-12-19 J.W. Speaker Corporation Tracking and lighting systems and methods for a vehicle
DE102015013191A1 (de) * 2015-10-10 2017-04-13 Daimler Ag Verfahren zum Betrieb einer Leuchteinheit und Leuchteinheit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100384979B1 (ko) * 1995-09-07 2003-10-17 에프. 호프만-라 로슈 아게 심부전증및신부전증치료용의신규한4-(옥시알콕시페닐)-3-옥시-피페리딘
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6197959B1 (en) * 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
US20040204455A1 (en) * 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
AR055756A1 (es) * 2005-03-31 2007-09-05 Speedel Experimenta Ag Piperidinas sustituidas; procesos de preparacion y su uso como medicamentos

Also Published As

Publication number Publication date
BRPI0608758A2 (pt) 2009-07-07
WO2006103277A2 (en) 2006-10-05
PT1863803E (pt) 2010-11-18
DE602006016573D1 (de) 2010-10-14
IL189429A0 (en) 2008-06-05
BRPI0621969A2 (pt) 2011-07-19
ATE479681T1 (de) 2010-09-15
US7687495B2 (en) 2010-03-30
JP2008201787A (ja) 2008-09-04
US20100029628A1 (en) 2010-02-04
EP1863803A2 (en) 2007-12-12
CA2601702A1 (en) 2006-10-05
JP2008534558A (ja) 2008-08-28
IL186130A0 (en) 2008-01-20
PL1863803T3 (pl) 2011-02-28
TW200833687A (en) 2008-08-16
EP1863803B1 (en) 2010-09-01
US20080171748A1 (en) 2008-07-17
WO2006103277A3 (en) 2006-12-28
AR065188A2 (es) 2009-05-20
AR055756A1 (es) 2007-09-05

Similar Documents

Publication Publication Date Title
TW200513461A (en) Organische verbindungen
TW200716622A (en) Substituted piperidines
GEP20094785B (en) Pyrrolopyrazoles, potent kinase inhibitors
NO20075273L (no) Nye forbindelser
TW200636046A (en) Novel materials for organic electroluminescent devices
TW200704751A (en) Novel materials for organic electroluminescent devices
WO2009046841A3 (de) Piperidin- und piperazinderivate zur behandlung von tumoren
TW200637853A (en) Fungicides
NO20075275L (no) Nye forbindelser
TW200611898A (en) Organic compounds
PL1682530T3 (pl) Podstawione pirolo-indole jako inhibitory PAI-1
WO2006072615A3 (en) Triazolophthalazines as pde2-inhibitors
TW200637837A (en) Fungicides
TW200728277A (en) Bicyclic derivatives as P38 inhibitors
MX2010002245A (es) Derivados de ariloxiacetamida bi o triciclicos, saturados e insaturados y su uso como fungicidas.
EP1881975B8 (en) N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
WO2006061417A3 (en) Macrocyclic quinazole derivatives and their use as mtki
TW200706637A (en) Imidazole derivatives and organic electronic device using the same
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
NO20045025L (no) Nye forbindelser
GB0508314D0 (en) Organic compounds
WO2007120333A3 (en) Tetracyclic kinase inhibitors
TW200700358A (en) Organic compounds
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
WO2007000340A3 (en) Bicyclic derivatives as p38 kinase inhibitors